Indivior Plc notched a legal victory on Tuesday after a U.S. court reaffirmed that a generic rival could not re-launch cheaper versions of the British drugmaker's best-selling opioid addiction treatment in the United States.
from Reuters: Health https://ift.tt/2LFmNly
via IFTTT
0 comments: